Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Dark times: iminothioindoxyl-C-nucleoside fluorescence quenchers with defined location and minimal perturbation in DNA

Larita Luma a, Judith C. Pursteiner a, Tobias Fischer b, Rainer Hegger b, Irene Burghardt *b, Josef Wachtveitl *b and Alexander Heckel *a
aGoethe University Frankfurt, Institute for Organic Chemistry and Chemical Biology, Max-von-Laue-Str. 7, 60438 Frankfurt, Germany. E-mail: heckel@uni-frankfurt.de
bGoethe University Frankfurt, Institute for Physical and Theoretical Chemistry, Max-von-Laue-Str. 7, 60438 Frankfurt, Germany. E-mail: wveitl@theochem.uni-frankfurt.de; burghardt@chemie.uni-frankfurt.de

Received 2nd August 2024 , Accepted 30th August 2024

First published on 4th September 2024


Abstract

Fluorescence quenchers for application in DNA – like the BHQ family – tend to be large molecules which need to be attached, often post-synthetically, via long linkers. In this study, we present two new iminothioindoxyl-C-nucleosidic quenchers which are very compact, feature a native backbone and can be introduced into DNA via regular solid-phase synthesis. Especially with dT as juxtaposed nucleobase, they have a defined location and orientation in a DNA duplex with minimal perturbation of the structure and hence interaction capabilities. Depending on the nature of the fluorophore, they can be used for orientation-(un)specific FRET studies. Their Förster radius is smaller than the one of BHQ-2. This makes these quenchers ideal for sophisticated studies using conditional quenching in the range between 470 and 670 nm in DNA.


Introduction

Fluorophores are an essential tool in cell biology and biochemistry.1 The use of fluorophores enables the investigation of a wide variety of biological processes in real time with detection limits down to single molecules.2 Tracking biomolecules such as oligonucleotides,3–7 proteins8 or lipids9 allows characterization of complex biological functions, the investigation of enzymatic activities and cellular signaling pathways. The versatility of fluorophore-labeled biomolecules extends across the fields of molecular diagnostics,10 drug development,11 molecular beacons,12–14 aptamers15,16 and microscopy applications.17,18

The application of fluorophores is even more useful, if their fluorescence is conditional – depending on local properties of the sample – by using quencher strategies, e.g. in a distance-dependent FRET effect.8,15–18 A very prominently-used quencher family is based on azobenzene-derived compounds like DABCYL.19,20 By expanding the chromophore, universal dark quencher systems like the BHQ (“black hole quencher”) series became accessible, covering a broad spectral range.21,22 As a consequence of this engineering of λmax and ε for an optimal FRET efficiency, modern systems are rather large molecules. However, in many biologically active systems, small changes in the structure can cause a strong impact.23,24 Therefore, in the majority of cases, the established quenchers have to be attached via long, flexible linkers – outside of the main structure. This inevitable necessity positions the quencher away from otherwise desired, well-defined locations.

FRET-labels can be implemented via solid-phase synthesis or bioconjugation into oligonucleotides. By solid-phase synthesis, quenchers can be introduced terminally using 3′-modified solid support25 or 5′-modifiers.26–28 Within the sequence, specialized phosphoramidites are used, but only a handful of quencher molecules are directly accessible. In other cases, to avoid side reactions, phosphoramidites with an orthogonal coupling site are used and the quencher is installed post-synthetically in an additional coupling and purification step.29 Thus, for the majority of the commercially available quenchers there is no universal strategy for the introduction into oligonucleotides.

For fluorophore-quencher pairs there are many fascinating applications in an oligonucleotide context using several strategies.30,31 The development of chromophore-C-nucleosides by Kool32–35 and Leumann,36–39 is of particular importance in the context of this study. Leumann introduced for example hydrophobic biphenyl-C-nucleosides as FRET pairs into DNA oligonucleotides.4,38 Wilhelmsson developed unique nucleoside analogues as FRET pairs by π-system extension of the nucleobase.40–42 They characterized the structure and dynamics of DNA and RNA duplexes, utilizing the well-defined position and fixed orientation of their fluorophore-quencher pairs.43–47 Asanuma also introduced pyrene- and perylene-based FRET pairs in a fixed orientation due to π-stacking for characterization of DNA structure photo-dimerization.48,49 Sigurdsson showed that fluorescence, quenching and EPR spin label properties can be combined in nucleoside analogues that also have a fixed position in a duplex structure and can be used for investigations of RNA conformation and dynamics.50 However, the number of available quencher systems with rigid structures, a native backbone and good photophysical properties, including the absorption coefficient and the absorption maximum, remains very limited.

In this work, two new quencher systems were established which feature a compact molecular structure in a rigid C-nucleosidic design that is compatible with a natural deoxyribose-phosphodiester backbone (Fig. 1a). Iminothioindoxyls (ITIs) are an emerging class of chromophores.51,52 In a previous study, we showed that their excited state decays surprisingly fast in a few picoseconds and used ITI-derivatives for time-resolved IR spectroscopy in a peptide context.53 Like in the previous study, we chose to use a dimethylamino- (DMA-ITI-C-nucleoside 1a) or julolidine- (J-ITI-C-nucleoside 1b) modification (“distal aromatic ring”) on the iminothioindoxyl core (“proximal aromatic ring”). Our decision to use C-nucleosides was motivated by previous experience, where we engineered photoswitches into oligonucleotide duplexes for reversible photocontrol of hybridization.54–56


image file: d4sc05175k-f1.tif
Fig. 1 (a) The iminothioindoxyl-(ITI)-derived quencher nucleosides 1a and 1b introduced in this study. (b and c) Side and top views of our initial design idea (not geometry-optimized) in which one nucleoside of a dsDNA is replaced by nucleoside 1b opposite a dA or dT residue, respectively. For comparison, an unperturbed Watson–Crick–Franklin base pair is shown with faded colors. (d) Positioning of the ITI chromophores of compounds 1a and 1b in the native duplex structure viewed along the helix axis (not geometry-optimized).

Fig. 1b–d shows schematic illustrations of our initial design idea where a nucleoside in a dsDNA structure was replaced with compounds 1a and 1b, respectively. Panel 1b shows the (larger) J-ITI-C-nucleoside 1b opposite of a dA residue and panel 1c opposite of a dT residue, both from different, perpendicular, viewing angles. The corresponding pictures for the (smaller) DMA-ITI-C-nucleoside 1a are provided in the ESI (Section 5.3). From these illustrations, we expected a medium local influence on the duplex structure with a purine as juxtaposed nucleoside and an even smaller effect in the case of a pyrimidine. These preliminary considerations suggested that the proximal benzothiophenone part of the ITI could potentially be incorporated into the π-stacked base-pair ladder. It also suggested that even the larger of the two distal aromatic rings could still be accommodated in the minor groove.

Results and discussion

Starting from TIPDS-protected ribonolactone (2),57,58 the benzothiophenone (BTP) moiety was introduced by a nucleophilic attack to the 1′-position of a suitable precursor after lithium-halogen-exchange (→3, Scheme 1). Recovery of the ribose scaffold was performed by Lewis acid-catalyzed dehydroxylation (→4).59 The desired β-configuration was restored with an anomeric ratio of >90%, shown in ROESY-NMR spectroscopy (ESI, Section 2). The free nucleoside 5 was obtained after TBAF deprotection of the silyl-protecting groups. The distal aromatic ring was introduced utilizing an intermolecular aldol-like condensation with previously prepared nitroso compounds to yield DMA-/J-ITI-nucleosides 1a/b. For incorporation of nucleoside 1a/b into oligonucleotides via solid-phase synthesis, the 5′-OH group was tritylated (6a/b) and the 3′-OH group was phosphitylated (7a/b). A detailed description of the synthesis is provided in the ESI (Section 1).
image file: d4sc05175k-s1.tif
Scheme 1 Synthesis of ITI phosphoramidites 7a/b. (i) THF, compound S2 (see Scheme S1, ESI), nBuLi, −78 °C, 1.5 h, 55%. (ii) 1 DCM BF3·OEt2, Et3SiH, −78 °C, 4.5 h, 84%. (iii) THF, TBAF, rt, 2 h, 86%. (iv) EtOH, 1 M NaOH, DMA-/J-NO, rt, 16 h, 60%/58%. (v) DCM, pyridine, DMT-Cl, 0 °C – rt, 24 h, 34%/44%. (vi) DCM, DIPEA, PN(iPr)2OCE-Cl, rt, 2.5 h, 44%/92%.

Apart from the structural properties of quencher molecules, their photochemical properties are of great importance. The molar absorbance spectra of compounds 1a and 1b in MeOH and MeOH/PBS (pH 7.4) are shown in Fig. 2 and Table 1. Despite their small molecular structure, they have relatively high absorption bands in the visible range between 450 and 650 nm with maximal molar absorbance coefficients of 25[thin space (1/6-em)]900 to 33[thin space (1/6-em)]200 M−1 cm−1 (see also ESI, Section 3) – albeit not as high as the ones of the typical azobenzene-based quenchers. In comparison, the absorption coefficients of DABCYL, BHQ-1, BHQ-2 and BHQ-3 are 32[thin space (1/6-em)]000 M−1 cm−1, 34[thin space (1/6-em)]000 M−1 cm−1, 38[thin space (1/6-em)]000 M−1 cm−1 and 42[thin space (1/6-em)]700 M−1 cm−1, respectively.2 The full widths at half maximum (FWHM) of the adsorption bands are in the range of 97–119 nm, while for example the one of BHQ-2 is 139 nm.60 It depends on the type of application, whether wider or more narrow FWHM values are preferred. The latter are for example advantageous in multi-color applications.61,62


image file: d4sc05175k-f2.tif
Fig. 2 (a) Chemical structures of quencher and fluorophore moieties incorporated for oligonucleotide modification. (b) Overview of the emission spectra of the fluorophores Cy3 and ATTO Rho11 as small molecules (dashed lines and filled areas)60 as well as the absorbance spectra of the DMA-ITI-, J-ITI- and BHQ-2-modified oligonucleotides of this study (solid lines).
Table 1 Absorption properties of DMA-ITI-1a and J-ITI-C-nucleoside 1b
Compound Solvent λ max/nm ε/M−1 cm−1 FWHM/nm
a Water, hexafluoroisopropanol (0.4 M), Et3N (16.3 mM), pH 7.9.
1a MeOH 519 27[thin space (1/6-em)]000 97
1a MeOH/PBS 1[thin space (1/6-em)]:[thin space (1/6-em)]1 539 25[thin space (1/6-em)]900 111
ON DMA int MeOH/buffera 548 24[thin space (1/6-em)]400 112
1b MeOH 563 33[thin space (1/6-em)]200 105
1b MeOH/PBS 1[thin space (1/6-em)]:[thin space (1/6-em)]1 591 31[thin space (1/6-em)]000 119
ON J int MeOH/buffera 602 31[thin space (1/6-em)]300 124


In additional ultrafast UV-Vis transient absorption measurements, the relaxation behavior and dynamics of the ITI-derivatives were characterized (ESI, Section 4). Both derivatives are permanently present in their Z-conformation, showing no formation of long-lived photoproducts due to photo-isomerization or other productive pathways after excitation. Relaxation takes place within a few picoseconds exclusively via vibrational deexcitation.

To test the quenching properties of our new compounds 1a/b, we chose the commercially available Cy3 and ATTO Rho11 as fluorophores (Fig. 2a). Based on the respective emission and absorbance properties (Fig. 2b), we combined Cy3 with DMA-ITI as well as ATTO Rho11 with J-ITI. As reference quencher dT-BHQ-2 was selected, which can be used as quencher for either fluorophore.

These modifications were investigated in an oligonucleotide context. To that end, phosphoramidites 7a/b were incorporated using standard solid-phase synthesis procedures (Fig. 3 and ESI Section 5). Potential hydrolysis of the imine in the ITI was only observed in the presence of for example 80% acetic acid, which is why we recommend a DMT-OFF strategy for the solid-phase synthesis. The sequence was selected to have no stable secondary structures and a suitable melting temperature.63 Also, we avoided guanine in the immediate vicinity of the fluorophore as the guanosine residue itself has a fluorescence quenching effect based on the photo-induced electron transfer (PET)64,65 between the fluorescence dye and the nucleobase.66–70 The quenching properties of guanosine have been used for the development of “quencher-free” molecular beacons for example by Sauer and Kim.64,71,72 For the internal modification, a residue of the 21-mer was replaced, while the terminal modifications were added to the respective 5′- and 3′-ends so that the same antisense strands could be used for all sequences. The fluorophore-modified antisense strands were synthesized by NHS-labelling of the corresponding amino-functionalized oligonucleotides (ESI, Section 6).


image file: d4sc05175k-f3.tif
Fig. 3 (Modified) oligonucleotides used in this study. The internal or terminal position of the quencher modification is designated with Q, the one of the fluorophore with F.

Compared to the free nucleosides 1a/b in MeOH/PBS, in the oligonucleotides, λmax of the ITI chromophores' absorbance is slightly red-shifted by approximately 10 nm, the absorption coefficients are slightly reduced but only in the case of ONDMAint and the FWHM remains approximately the same. BHQ-2 on the other hand experiences a slight increase in the absorbance coefficient (38[thin space (1/6-em)]000–40[thin space (1/6-em)]700 M−1 cm−1) upon introduction into ONBHQ2int, while λmax (579 nm–574 nm) and the FWHM remain approximately the same (139 nm–144 nm).

To evaluate the quenching effects, fluorescence studies were performed with different fluorophore/quencher strand ratios (100[thin space (1/6-em)]:[thin space (1/6-em)]1, 10[thin space (1/6-em)]:[thin space (1/6-em)]1, 7[thin space (1/6-em)]:[thin space (1/6-em)]1, 3[thin space (1/6-em)]:[thin space (1/6-em)]1, 1[thin space (1/6-em)]:[thin space (1/6-em)]1, 1[thin space (1/6-em)]:[thin space (1/6-em)]3, 1[thin space (1/6-em)]:[thin space (1/6-em)]7, 1[thin space (1/6-em)]:[thin space (1/6-em)]10), keeping the fluorophore concentration constant (Fig. 4 and ESI Section 7). For the fluorophore/quencher pair Cy3 and DMA-ITI, the fluorescence was quenched to 33% (1[thin space (1/6-em)]:[thin space (1/6-em)]1) and 13% (1[thin space (1/6-em)]:[thin space (1/6-em)]10) for the internal modification, respectively. For the terminal modification, we observed an even lower fluorescence: 21% (1[thin space (1/6-em)]:[thin space (1/6-em)]1) and 9% (1[thin space (1/6-em)]:[thin space (1/6-em)]10).


image file: d4sc05175k-f4.tif
Fig. 4 Fluorescence studies of the F/Q-pair-modified oligonucleotide duplexes. The respective F-labelled strand serves as the reference for maximum fluorescence. (a) Fluorescence quenching of Cy3 with DMA-ITI-C-nucleoside 7a internal (dark red), terminal (light red). (b) Fluorescence quenching of ATTO Rho11 with J-ITI-C-nucleoside 7b internal (dark blue), terminal (light blue). For both fluorophores dT-BHQ-2 internal (dark grey), terminal (light grey) was used for comparison.

With the J-ITI quencher, featuring the larger distal aromatic ring, and with ATTO Rho11 we found 24% (1[thin space (1/6-em)]:[thin space (1/6-em)]1) and 8% (1[thin space (1/6-em)]:[thin space (1/6-em)]10) for the internal, as well as 12% (1[thin space (1/6-em)]:[thin space (1/6-em)]1) and 5% (1[thin space (1/6-em)]:[thin space (1/6-em)]10) for the terminal modification. In the direct comparison of these numbers, one has to keep in mind that in the fluorophore/BHQ-2 pairs will most likely perform contact quenching, as both chromophores are attached via long linkers in the major groove.3,61,73 In the fluorophore-ITI pairs, this is impossible and the quenching is most likely FRET-based. The calculated Förster radius R0 of ONCy3int:ONDMAint is 4.7 nm, while the one of ONCy3int:ONBHQ2int is 5.3 nm. Likewise, R0 for ONATTOint:ONJint is 6.1 nm, while the one for ONATTOint:ONBHQ2int is 6.3 nm. Thus, R0 for our new quenchers is smaller compared to BHQ-2. This can be advantageous in specific applications.74,75

For quantitative FRET measurements, it is also important to consider the influence of the orientation of the two chromophores (κ) as evidenced in the work by Sauer and Seidel as well as Wilhelmsson and Asanuma.47–49,76 For two freely-rotating chromophores, κ2 is often approximated as 2/3 (i.e. isotropic average). With our quenchers, which have a fixed position in the base pair stack, both scenarios are possible: with a freely rotating donor (as in our examples), the same approximation is still valid, whereas with a fixed donor, experiments with a more complicated κ-dependence are possible. We then tested the influence of our quenching residues on the structure by melting temperature studies and CD spectroscopy (Table 2 and ESI, Sections 8 and 9). All measurements were carried out under identical conditions comparing the set of BHQ-2, DMA-ITI and J-ITI. The first measurements were performed with a purine dA as the juxtaposed nucleobase (WT2dA as antisense strand) – which was expected to be still too large for a minimal perturbation. The melting temperature of the native duplex was determined to be 70.3 °C. As expected, terminal modification has little or no effect due to the increased degrees of freedom, although it should be emphasized that BHQ-2 shows the greatest perturbation. With internal modification, a larger ΔTm was observed for all three constructs. DMA-ITI shows the largest interference with 7 °C despite its small structure. BHQ-2 and J-ITI induce a significantly lower perturbation with ΔTm of 4–4.5 °C. CD spectroscopy showed that the structure of a native B-helix is preserved and that only minor deviations are induced by all the constructs described above, consistent with the results of the melting temperature study.

Table 2 Overview of the results of melting temperature studies between the indicated, modified oligonucleotide strands
Antisense strand: WT2dA Antisense strand: WT2dT
Sense strand T m/ °C ΔTm/ °C Sense strand T m/ °C ΔTm/ °C
WT1 dT 70.3 WT1 dA 67.7
ON DMA term 70.5 +0.2
ON J term 71.1 +0.8
ON BHQ2 term 68.7 −1.6
ON DMA int 63.3 −7.0 ON DMA int 65.7 −2.0
ON J int 65.8 −4.5 ON J int 66.4 −1.3
ON BHQ2 int 66.2 −4.1 ON BHQ2 int 66.5 −1.2


The next series of tests was performed with a pyrimidine dT as the opposite nucleobase (WT2dT as antisense strand) from which we expected a much better fit in our initial considerations. Indeed, we observed that the entire trio induces a significantly smaller perturbation of only 1.2–2.0 °C.

Interestingly, the temperature-dependent hyperchromicity of the nucleobase absorption band at 260 nm coincides with the temperature-dependent hypsochromic shift of the quenchers' absorbances (ESI Section 3.2) – further supporting the hypothesis of base stacking of the new quenchers.

To probe the local perturbation further, we performed molecular dynamics (MD) simulations. All-atom MD simulations confirm that the proximal aromatic ring of the quencher exhibits π-stacking that is very similar to the one of native interactions. This is illustrated in Fig. 5 – taken from a typical simulation run – which shows the quencher and its local environment (Fig. 5a). The julolidine ring is twisted to follow the path of the minor groove. For the WT2dA-modified duplex, Fig. 5b shows the distance parameter d between the proximal aromatic ring of the J-ITI-C-nucleoside 1b and the upper neighboring nucleobase as a function of time, along with the tilt angle α between the normal vectors pertaining to these moieties. A similar analysis is shown in Fig. 5c for the WT2dT duplex. The deviations of both the d and α quantities from their average values are similar to the ones found in native π-stacking, as illustrated in Section 10 of the ESI. However, the π-stacking interaction with the lower nucleobase is less tight and prone to stronger fluctuations, as also shown in Section 10 of the ESI. Our simulations further suggest that the distal aromatic ring of the J-ITI-C-nucleoside 1b is rotated with respect to the plane of the proximal aromatic ring, following the path of the minor groove, and is perfectly accommodated in the latter. These results all support our initial design ideas (Fig. 1b and c) regarding the perturbation potential of our modifications with a purine or pyrimidine as the adjacent nucleobase. Previous quencher systems require long spacers to position the sterically demanding chromophore outside of the base stack. In contrast, our DMA- and J-ITI-C-nucleosides use a deoxyribose with β-configuration at the anomeric center as the smallest, most native point of attachment to the oligonucleotide backbone.


image file: d4sc05175k-f5.tif
Fig. 5 (a) Representative snapshot taken from an all atom MD simulation at T = 300 K, with the J-ITI-C-nucleoside 1b highlighted in blue. The stacking distance parameter d and the tilt angle α between normal vectors of the proximal aromatic ring of the quencher and upper nucleobase (marked in green and orange, respectively) measure stacking fluctuations. (b) Time traces for the parameters d and α for the WT2dA modified duplex (see Table 2). (c) Corresponding time traces of the parameters d and α for the WT2dT duplex.

Conclusion

We present two new C-nucleosidic quenchers based on an iminothioindoxyl (ITI) chromophore system. They have a relatively small, rigid structure compared to other quenchers like the BHQ family and were designed to fit with minimal perturbation of the native structure as nucleotide replacement in a DNA duplex opposite a pyrimidine nucleoside. Thermal melting studies and MD simulations support the idea that the quenchers are part of the base-pair stack in a fixed position. This is in contrast to for example the BHQ family of quenchers, which are too large for a DNA duplex and are usually attached via a flexible linker in the major groove, where proteins are known to interact with a DNA duplex. Since our quenchers have a native deoxyribose backbone, they can be introduced via solid-phase synthesis in any position of the oligonucleotide.

The molar absorption coefficients of our quenchers are smaller than the ones of the BHQ family but still in the same order of magnitude – despite their small size. Importantly, their Förster radius is smaller than the ones of the BHQ derivatives. Also, their absorption is surprisingly far in the green/red part of the spectrum. Choosing either a conformationally restricted or a flexible FRET donor, different types of orientation-(un)specific spectroscopic investigations are possible.

While quenchers and fluorophores attached to dsDNA via long linkers offer the potential for contact quenching and hence a minimal fluorescent background, we believe that the strength of our quenchers lies in different directions of application: superresolution microscopy could profit from the small Förster radius.74,75 Spectroscopic studies on the dynamic folding of aptamers and riboswitches will profit from the small size, minimal perturbation and well-defined position and do not require full quenching.77 Also, functional biological studies may profit from the small size and fixed location of our quenchers.78

Data availability

The data supporting this article have been included as part of the ESI.

Author contributions

L. L.: conceptualization, data curation, investigation, resources, formal analysis, visualization, writing – original draft, writing – review & editing. J. P.: data curation, investigation, resources, formal analysis. T. F.: data curation, investigation, formal analysis, visualization. R. H.: simulations, investigation, formal analysis, visualization. I. B.: funding acquisition, project administration, writing – review & editing. J. W.: funding acquisition, project administration, writing – review & editing. A. H.: conceptualization, funding acquisition, project administration, writing – original draft, writing – review & editing.

Conflicts of interest

There are no conflicts to declare.

Acknowledgements

This research was funded by the Deutsche Forschungs-gemeinschaft (DFG) (GRK1986 “CLiC”, INST 161/722-1). We thank Mike Heilemann for very fruitful discussions in the context of this study.

Notes and references

  1. M. S. T. Gonçalves, Chem. Rev., 2009, 109, 190–212 CrossRef .
  2. B. Fang, Y. Shen, B. Peng, H. Bai, L. Wang, J. Zhang, W. Hu, L. Fu, W. Zhang, L. Li and W. Huang, Angew. Chem., Int. Ed., 2022, 134, e2022071 Search PubMed .
  3. S. A. E. Marras, F. R. Kramer and S. Tyagi, Nucleic Acids Res., 2002, 30, e122 CrossRef PubMed .
  4. M. Stoop, A. Zahn and C. J. Leumann, Tetrahedron, 2007, 63, 3440–3449 CrossRef CAS .
  5. S. Berndl and H.-A. Wagenknecht, Angew. Chem., Int. Ed., 2009, 48, 2418–2421 CrossRef CAS PubMed .
  6. J. Steinmeyer, F. Rönicke, U. Schepers and H.-A. Wagenknecht, ChemistryOpen, 2017, 6, 514–518 CrossRef CAS PubMed .
  7. B. Pfeuffer, P. Geng and H.-A. Wagenknecht, ChemBioChem, 2024, 25, e202300739 CrossRef CAS PubMed .
  8. G. Agam, C. Gebhardt, M. Popara, R. Mächtel, J. Folz, B. Ambrose, N. Chamachi, S. Y. Chung, T. D. Craggs, M. De Boer, D. Grohmann, T. Ha, A. Hartmann, J. Hendrix, V. Hirschfeld, C. G. Hübner, T. Hugel, D. Kammerer, H.-S. Kang, A. N. Kapanidis, G. Krainer, K. Kramm, E. A. Lemke, E. Lerner, E. Margeat, K. Martens, J. Michaelis, J. Mitra, G. G. Moya Muñoz, R. B. Quast, N. C. Robb, M. Sattler, M. Schlierf, J. Schneider, T. Schröder, A. Sefer, P. S. Tan, J. Thurn, P. Tinnefeld, J. Van Noort, S. Weiss, N. Wendler, N. Zijlstra, A. Barth, C. A. M. Seidel, D. C. Lamb and T. Cordes, Nat. Methods, 2023, 20, 523–535 CrossRef CAS PubMed .
  9. A. S. Klymchenko, Acc. Chem. Res., 2023, 56, 1–12 CrossRef CAS .
  10. J. Zhang, X. Chai, X.-P. He, H.-J. Kim, J. Yoon and H. Tian, Chem. Soc. Rev., 2019, 48, 683–722 RSC .
  11. E. Garrido, L. Pla, B. Lozano-Torres, S. El Sayed, R. Martínez-Máñez and F. Sancenón, ChemistryOpen, 2018, 7, 401–428 CrossRef CAS PubMed .
  12. S. Tyagi and F. R. Kramer, Nat. Biotechnol., 1996, 14, 303–308 CrossRef CAS PubMed .
  13. K. Wang, Z. Tang, C. J. Yang, Y. Kim, X. Fang, W. Li, Y. Wu, C. D. Medley, Z. Cao, J. Li, P. Colon, H. Lin and W. Tan, Angew. Chem., Int. Ed., 2009, 48, 856–870 CrossRef CAS .
  14. P. G. Donlin-Asp, C. Polisseni, R. Klimek, A. Heckel and E. M. Schuman, Proc. Natl. Acad. Sci. U.S.A., 2021, 118, e2017578118 CrossRef CAS .
  15. C. Steinmetzger, C. Bäuerlein and C. Höbartner, Angew. Chem., Int. Ed., 2020, 59, 6760–6764 CrossRef CAS PubMed .
  16. C. Steinmetzger and C. Höbartner, in Nucleic Acid Aptamers. Methods in Molecular Biology, ed. G. Mayer and M. M. Menger, Humana, New York, NY, 2nd edn, 2023, vol. 2570, pp. 155–173 Search PubMed .
  17. F. Wehnekamp, G. Plucińska, R. Thong, T. Misgeld and D. C. Lamb, eLife, 2019, 8, e46059 CrossRef .
  18. F. Mieskes, E. Ploetz, F. Wehnekamp, V. Rat and D. C. Lamb, Small, 2023, 19, 2204726 CrossRef CAS .
  19. R. M. Cook, M. Lyttle and D. Dick, World Intellectual Property Organization, WO 2001086001A1, 2001.
  20. R. M. Cook, M. Lyttle and D. Dick, US Pat.7019129B1, 2006 Search PubMed .
  21. A. Chevalier, C. Massif, P.-Y. Renard and A. Romieu, Chem.–Eur. J., 2013, 19, 1686–1699 CrossRef CAS PubMed .
  22. A. Chevalier, J. Hardouin, P.-Y. Renard and A. Romieu, Org. Lett., 2013, 15, 6082–6085 CrossRef CAS .
  23. J. Gao, H. Liu and E. T. Kool, J. Am. Chem. Soc., 2004, 126, 11826–11831 CrossRef CAS .
  24. S. Chatterjee, S. Basu, N. Ghosh and M. Chakrabarty, Spectrochim. Acta, Part A, 2005, 61, 2199–2201 CrossRef PubMed .
  25. P. Theisen, C. McCullum, K. Upadhya, K. Jacobson, H. Vu and A. Andrus, Tetrahedron Lett., 1992, 33, 5033–5036 CrossRef CAS .
  26. F. Suhubert, K. Ahlert, D. Cech and A. Rosenthal, Nucleic Acids Res., 1990, 18, 3427 CrossRef .
  27. V. A. Korshun, N. B. Pestov, K. R. Birikh and Yu. A. Berlin, Bioconjugate Chem., 1992, 3, 559–562 CrossRef CAS PubMed .
  28. F. D. Lewis, Y. Zhang and R. L. Letsinger, J. Am. Chem. Soc., 1997, 119, 5451–5452 CrossRef CAS .
  29. U. Asseline, E. Bonfils, R. Kurfürst, M. Chassignol, V. Roig and N. T. Thuong, Tetrahedron, 1992, 48, 1233–1254 CrossRef CAS .
  30. C. Wojczewski, K. Stolze and J. W. Engels, Synlett, 1999, 10, 1667–1678 CrossRef .
  31. R. Varghese and H.-A. Wagenknecht, Chem. Commun., 2009, 2615 RSC .
  32. N. Chaudhuri, R. Ren and E. Kool, Synlett, 1997, 1997, 341–347 CrossRef PubMed .
  33. C. Strässler, N. E. Davis and E. T. Kool, Helv. Chim. Acta, 1999, 82, 2160–2171 CrossRef .
  34. A. Cuppoletti, Y. Cho, J.-S. Park, C. Strässler and E. T. Kool, Bioconjugate Chem., 2005, 16, 528–534 CrossRef CAS PubMed .
  35. J. N. Wilson and E. T. Kool, Org. Biomol. Chem., 2006, 4, 4265 RSC .
  36. C. Brotschi, A. Häberli and C. J. Leumann, Angew. Chem., Int. Ed., 2001, 40, 3012–3014 CrossRef CAS .
  37. C. Brotschi and C. J. Leumann, Angew. Chem., Int. Ed., 2003, 42, 1655–1658 CrossRef CAS PubMed .
  38. A. Zahn and C. J. Leumann, Bioorg. Med. Chem., 2006, 14, 6174–6188 CrossRef CAS .
  39. Z. Johar, A. Zahn, C. J. Leumann and B. Jaun, Chem.–Eur. J., 2008, 14, 1080–1086 CrossRef CAS .
  40. K. Börjesson, S. Preus, A. H. El-Sagheer, T. Brown, B. Albinsson and L. M. Wilhelmsson, J. Am. Chem. Soc., 2009, 131, 4288–4293 CrossRef PubMed .
  41. S. Preus, K. Börjesson, K. Kilså, B. Albinsson and L. M. Wilhelmsson, J. Phys. Chem. B, 2010, 114, 1050–1056 CrossRef CAS PubMed .
  42. S. Preus, K. Kilså, L. M. Wilhelmsson and B. Albinsson, Phys. Chem. Chem. Phys., 2010, 12, 8881 RSC .
  43. M. S. Wranne, A. F. Füchtbauer, B. Dumat, M. Bood, A. H. El-Sagheer, T. Brown, H. Gradén, M. Grøtli and L. M. Wilhelmsson, J. Am. Chem. Soc., 2017, 139, 9271–9280 CrossRef CAS PubMed .
  44. A. F. Füchtbauer, M. S. Wranne, M. Bood, E. Weis, P. Pfeiffer, J. R. Nilsson, A. Dahlén, M. Grøtli and L. M. Wilhelmsson, Nucleic Acids Res., 2019, 47, 9990–9997 CrossRef .
  45. A. Wypijewska del Nogal, A. F. Füchtbauer, M. Bood, J. R. Nilsson, M. S. Wranne, S. Sarangamath, P. Pfeiffer, V. S. Rajan, A. H. El-Sagheer, A. Dahlén, T. Brown, M. Grøtli and L. M. Wilhelmsson, Nucleic Acids Res., 2020, 48, 7640–7652 CrossRef PubMed .
  46. M. Bood, S. Sarangamath, M. S. Wranne, M. Grøtli and L. M. Wilhelmsson, Beilstein J. Org. Chem., 2018, 14, 114–129 CrossRef CAS .
  47. L. M. Wilhelmsson, in Fluorescent Analogs of Biomolecular Building Blocks, ed. M. Wilhelmsson and Y. Tor, John Wiley & Sons, Inc, Hoboken, NJ, 2016, pp. 224–241 Search PubMed .
  48. T. Kato, H. Kashida, H. Kishida, H. Yada, H. Okamoto and H. Asanuma, J. Am. Chem. Soc., 2013, 135, 741–750 CrossRef CAS .
  49. H. Kawai, T. Doi, Y. Ito, T. Kameyama, T. Torimoto, H. Kashida and H. Asanuma, Chem.–Eur. J., 2021, 27, 12845–12850 CrossRef CAS .
  50. H. Gustmann, D. Lefrancois, A. J. Reuss, D. B. Gophane, M. Braun, A. Dreuw, S. Th. Sigurdsson and J. Wachtveitl, Phys. Chem. Chem. Phys., 2017, 19, 26255–26264 RSC .
  51. M. W. H. Hoorens, M. Medved’, A. D. Laurent, M. Di Donato, S. Fanetti, L. Slappendel, M. Hilbers, B. L. Feringa, W. Jan Buma and W. Szymanski, Nat. Commun., 2019, 10, 2390 CrossRef PubMed .
  52. M. Medved’, M. W. H. Hoorens, M. Di Donato, A. D. Laurent, J. Fan, M. Taddei, M. Hilbers, B. L. Feringa, W. J. Buma and W. Szymanski, Chem. Sci., 2021, 12, 4588–4598 RSC .
  53. C. Feid, L. Luma, T. Fischer, J. G. Löffler, N. Grebenovsky, J. Wachtveitl, A. Heckel and J. Bredenbeck, Angew. Chem., Int. Ed., 2023, e202317047 Search PubMed .
  54. T. Goldau, K. Murayama, C. Brieke, H. Asanuma and A. Heckel, Chem.–Eur. J., 2015, 21, 17870–17876 CrossRef CAS PubMed .
  55. T. Goldau, K. Murayama, C. Brieke, S. Steinwand, P. Mondal, M. Biswas, I. Burghardt, J. Wachtveitl, H. Asanuma and A. Heckel, Chem.–Eur. J., 2015, 21, 2845–2854 CrossRef CAS .
  56. N. Grebenovsky, L. Luma, P. Müller and A. Heckel, Chem.–Eur. J., 2019, 25, 12298–12302 CrossRef CAS PubMed .
  57. D. Scarpi, L. Bartali, A. Casini and E. G. Occhiato, Eur. J. Org Chem., 2013, 2013, 1306–1317 CrossRef CAS .
  58. U. Wichai and S. A. Woski, Org. Lett., 1999, 1, 1173–1175 CrossRef CAS .
  59. N. A. Grigorenko and C. J. Leumann, Chem.–Eur. J., 2009, 15, 639–645 CrossRef CAS PubMed .
  60. T. Lambert, FPbase Fluorescence Spectra Viewer, https://www.fpbase.org/spectra/, accessed March 8, 2024 Search PubMed.
  61. S. A. E. Marras, Mol. Biotechnol., 2008, 38, 247–255 CrossRef CAS PubMed .
  62. A. Kaur and S. Dhakal, TrAC, Trends Anal. Chem., 2020, 123, 115777 CrossRef CAS .
  63. A. Rodrigues-Correia, M. B. Koeppel, F. Schäfer, K. B. Joshi, T. Mack and A. Heckel, Anal. Bioanal. Chem., 2011, 399, 441–447 CrossRef CAS PubMed .
  64. T. Heinlein, J.-P. Knemeyer, O. Piestert and M. Sauer, J. Phys. Chem. B, 2003, 107, 7957–7964 CrossRef CAS .
  65. O. Piestert, H. Barsch, V. Buschmann, T. Heinlein, J.-P. Knemeyer, K. D. Weston and M. Sauer, Nano Lett., 2003, 3, 979–982 CrossRef CAS .
  66. J. P. Schreiber and M. P. Daune, J. Mol. Biol., 1974, 83, 487–501 CrossRef CAS .
  67. Y. Kubota, Y. Motosa, Y. Shigemune and Y. Fujisaki, Photochem. Photobiol., 1979, 29, 1099–1106 CrossRef CAS .
  68. C. A. M. Seidel, A. Schulz and M. Sauer, J. Phys. Chem., 1996, 100, 5541–5553 CrossRef CAS .
  69. J. E. Noble, L. Wang, K. D. Cole and A. K. Gaigalas, Biophys. Chem., 2005, 113, 255–263 CrossRef CAS .
  70. D. Xiang, F. Li, C. Wu, B. Shi and K. Zhai, Talanta, 2017, 174, 289–294 CrossRef CAS PubMed .
  71. G. T. Hwang, Y. J. Seo and B. H. Kim, J. Am. Chem. Soc., 2004, 126, 6528–6529 CrossRef CAS PubMed .
  72. N. Venkatesan, Y. Jun Seo and B. Hyean Kim, Chem. Soc. Rev., 2008, 37, 648 RSC .
  73. M. K. Johansson, H. Fidder, D. Dick and R. M. Cook, J. Am. Chem. Soc., 2002, 124, 6950–6956 CrossRef CAS .
  74. K. K. H. Chung, Z. Zhang, P. Kidd, Y. Zhang, N. D. Williams, B. Rollins, Y. Yang, C. Lin, D. Baddeley and J. Bewersdorf, Nat. Methods, 2022, 19, 554–559 CrossRef CAS PubMed .
  75. L. F. Kessler, A. Balakrishnan, N. S. Deußner-Helfmann, Y. Li, M. Mantel, M. Glogger, H. Barth, M. S. Dietz and M. Heilemann, Angew. Chem., Int. Ed., 2023, 62, e202307538 CrossRef CAS .
  76. A. K. Woźniak, G. F. Schröder, H. Grubmüller, C. A. M. Seidel and F. Oesterhelt, Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 18337–18342 CrossRef .
  77. F. Hurter, A.-L. J. Halbritter, I. M. Ahmad, M. Braun, S. Th. Sigurdsson and J. Wachtveitl, Phys. Chem. Chem. Phys., 2024, 26, 7157–7165 RSC .
  78. M. Sustarsic and A. N. Kapanidis, Curr. Opin. Struct. Biol., 2015, 34, 52–59 CrossRef CAS .

Footnote

Electronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d4sc05175k

This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.